… for severe Covid-19 and who received remdesivir on a compassionate-use basis. Over a …
by Grein et al. may foster the use of drugs with unproven efficacy in patients with Covid-19. …

… We provided remdesivir on a compassionate-use basis to patients hospitalized with
Covid-19, the illness caused by infection with SARS-CoV-2. Patients were those with confirmed …

… We highly encourage other reports on similar Managed Access or compassionate use activity
in response to COVID‐19 indications in order to strengthen our collective understanding of …

… 53 adults with COVID-19 who received compassionate use remdesivir showed a 68…
compassionate-use remdesivir was well tolerated in pregnant and postpartum women with COVID-19…

… COVID-19 pandemic. Several drugs are being investigated as potential treatment for COVID-19,
… and regulatory framework, improving efficiency [19]. Findings presented here from 2009 …

… compassionate use in the era of COVID-19. Materials and Methods: In EU and Bulgaria as
well, the legal framework for compassionate use … COVID-19 through a compassionate use …

Children represent a minority of total COVID-19 cases, but studies have reported severe
disease and death in pediatric patients. Remdesivir (RDV) has recently demonstrated promising …

… of off-label use and compassionate use of drugs is that is that if … Considering that most patients
who have died from COVID-19 … are clinical manifestations of COVID-19, and both hepatic …

… with COVID-19 receiving remdesivir. Although the lack of a control in this compassionate-use …
, these data on remdesivir safety and outcomes in children with COVID-19 are important. …

… using off-label or compassionate use (CU) therapies, … COVID-19 era, it is essential for
Bulgarian patients to have early and expanded access to investigational drugs for compassionate …